Prevalence of sarcopenia in an Australian geriatric Medical Assessment Unit (MAU)

Not Applicable

• Conditions: sarcopenia; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12621000122853
• Lead Sponsor: Dr Lindsey Brett

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-08
• Study Completion: 2021-08-31
• Last Update Posted: 27 February 2023

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

Aged 65 years or older
- Admitted to the Prince of Wales Hospital geriatric MAU during the study period
- Able to provide written consent, or has a suitable representative that can provide consent on their behalf (e.g. power of attorney, family member)

Exclusion Criteria

- On end of life care pathway or terminally ill
- Severe medical or psychology diagnosis that would prevent participation in the sarcopenia assessment.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of sarcopenia in older adults admitted to an Australian geriatric Medical Assessment Unit (MAU) using the European Working Group on Sarcopenia in Older People’s (EWGSOP) algorithm.<br><br>This is a composite primary outcome, and includes:<br>Grip strength, which will be assessed using a Jamar dynamometer,<br>Muscle Mass, which will be assessed using a Impedimed Sozo Bioimpedance Spectroscopy (BIS),<br>Gait speed, which will be assessed using the 6m walk test..[Within 72 hours of admission to the MAU.]

Secondary Outcome Measures

Name	Time	Method
il[Nil]